Mackenzie Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$697K Buy
19,160
+502
+3% +$18.3K ﹤0.01% 1115
2025
Q1
$676K Buy
18,658
+2,543
+16% +$92.1K ﹤0.01% 1097
2024
Q4
$678K Buy
16,115
+11,825
+276% +$497K ﹤0.01% 1050
2024
Q3
$238K Buy
+4,290
New +$238K ﹤0.01% 1296